akhatri

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that the annual #MedSafetyWeek campaign is taking place from 2 to 8 November 2026 to promote the importance of reporting side effects from medicines and medical device incidents. This year’s theme is ‘Side effects: don’t ignore them, report them!’ The Yellow Card scheme relies on [...]

The post MHRA Drug Safety Update: #MedSafetyWeek (2 to 8 November 2026) appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 November 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Ipratropium bromide 250micrograms/1ml nebuliser liquid unit dose vials Atrovent® 250micrograms/1ml nebuliser liquid UDVs (Boehringer [...]

The post 3 products re-classified as special containers from November 2026 appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) Drug alert number: EL(26)A/42 Date issued: 12 October 2026 Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations. DMRC reference number: DMRC-41054154 Company name: [...]

The post MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification (MSN) for: Lacidipine 2mg and 4mg tablets. MSN/2026/046 Tier 2 – medium impact Date of issue: 6 October 2026 Lacidipine 2mg and 4mg tablets are out of stock until early November 2026 Lercanidipine 10mg and 20mg tablets remain available and can [...]

The post Medicine Supply Notification: Lacidipine 2mg and 4mg tablets appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: MOVICOL Plain 13.7g powder for oral solution (Norgine Limited) Drug Alert Number: EL(26)A/41 Date issued: 5 October 2026 Norgine Limited is recalling specific batches of product as a precautionary measure due to some units containing the incorrect amounts of active ingredients. DMRC reference number:DMRC-40129134 Marketing Authorisation Holder: Norgine Limited Medicine Details [...]

The post MHRA Class 3 Medicines Recall: MOVICOL Plain 13.7g powder for oral solution (Norgine Limited) appeared first on Community Pharmacy England.